In vitro studies evaluating the activity of imipenem in combination with relebactam against Pseudomonas aeruginosa

In vitro studies evaluating the activity of imipenem in combination with relebactam against Pseudomonas aeruginosa

Abstract Background The prevalence of antibiotic resistance is increasing, and multidrug-resistant Pseudomonas aeruginosa has been identified as a serious threat to human health. The production of β-lactamase is a key mechanism contributing to imipenem resistance in P. aeruginosa. Relebactam is a no...

Full description

Bibliographic Details
Main Authors: Katherine Young, Ronald E. Painter, Susan L. Raghoobar, Nichelle N. Hairston, Fred Racine, Douglas Wisniewski, Carl J. Balibar, Artjohn Villafania, Rumin Zhang, Daniel F. Sahm, Timothy Blizzard, Nicholas Murgolo, Milton L. Hammond, Mary R. Motyl
Format: Article
Language:English
Published: BMC 2019-07-01
Series:BMC Microbiology
Subjects:
β-Lactamase inhibitor
Carbapenem-resistant
Carbapenemase
Multidrug-resistant
MK-7655
Imipenem/relebactam
Online Access:http://link.springer.com/article/10.1186/s12866-019-1522-7

Internet

http://link.springer.com/article/10.1186/s12866-019-1522-7

Similar Items